Mode
Text Size
Log in / Sign up

Bone conduction hearing devices improve quality of life in adults with chronic otitis media hearing lossBone conduction hearing devices may improve quality of life for adults with chronic ear infections

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider bone conduction devices for COM hearing loss, but note evidence is from small, non-randomized studies.

This meta-analysis pooled data from nine non-randomized studies involving 107 adults with chronic otitis media and associated hearing loss. The intervention studied was the use of a bone conduction hearing device (BCHD). No comparator group was reported in the analysis.

The primary outcome was health-related quality of life (HRQoL). BCHD use was associated with a significant improvement in HRQoL, with a standardized mean difference (SMD) of 35.50 (95% confidence interval = 20.37 to 50.62, p < 0.001). For the secondary outcome of audiological function, pure tone audiometry showed improvements ranging from 38 to 52 dB, though specific effect sizes and statistical measures for this outcome were not reported.

Safety and tolerability data were not reported in the meta-analysis. Key limitations include the exclusive use of non-randomized study designs and a small total sample size of 107 participants. The authors rated the included studies as moderate to high quality but noted the need for larger controlled studies to strengthen the evidence base.

In practice, this analysis suggests BCHDs may be associated with meaningful quality of life and hearing improvements for adults with chronic otitis media-related hearing loss. However, clinicians should interpret these findings cautiously due to the observational nature of the evidence and limited sample, which preclude definitive causal conclusions and may affect generalizability.

Researchers reviewed nine existing studies to see if bone conduction hearing devices help adults with chronic ear infections and hearing loss. These devices work by sending sound vibrations through the bone of the skull directly to the inner ear, bypassing the damaged middle ear. The studies involved a total of 107 adults with this condition.

The review found that using these devices was linked to a significant improvement in people's health-related quality of life. This means people reported feeling better about their daily lives and hearing abilities. The studies also showed consistent improvements in hearing test results, with gains of 38 to 52 decibels.

It's important to be cautious because all the studies in this review were small and not randomized controlled trials. This type of study design makes it harder to be sure the device itself caused the improvements, rather than other factors. No safety concerns were reported in the review, but the studies did not focus on tracking side effects. Readers should see this as promising early evidence that needs confirmation from larger, more rigorous studies.

What this means for you:
Early review suggests a hearing device may help, but more research is needed to be certain.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
ObjectiveTo evaluate the effectiveness of bone conduction hearing device (BCHD) in improving health-related quality of life (HRQoL) among the adults chronic otitis media (COM) patients with hearing loss.MethodA systematic literature search was conducted in PubMed, Scopus, Embase and Cochrane Library for studies published between 1 Feb, 2015 to 15 February, 2025 that reported HRQoL outcomes in adult COM patients using BCHDs. Study quality was assessed using the Newcastle-Ottawa Scale, and, and results were synthesized with a random-effect model.ResultsNine non-randomized studies (n = 107) were included. BCHD significantly improved HRQoL (SMD = 35.50; 95% CI = 20.37–50.62, p < 0.001) with consistent audiological gains (pure tone audiometry improvements of 38–52 dB). Studies were rated as moderate to high quality.ConclusionBCHDs provide substantial positive effects on HRQoL for adults with COM-related hearing loss, representing an important public health intervention. Future research should employ larger controlled studies to strengthen the evidence base for policy and practice.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.